Systemically dispersed innate IL-13–expressing cells in type 2 immunity

April E. Price(Howard Hughes Medical Institute), Hong-Erh Liang(Howard Hughes Medical Institute), Brandon M. Sullivan(Howard Hughes Medical Institute), R. Lee Reinhardt(Howard Hughes Medical Institute), Chris J. Eisley(University of California, San Francisco), David J. Erle(University of California, San Francisco), Richard M. Locksley(Howard Hughes Medical Institute)
Proceedings of the National Academy of Sciences
June 7, 2010
Cited by 1,110

Abstract

Type 2 immunity is a stereotyped host response to allergens and parasitic helminths that is sustained in large part by the cytokines IL-4 and IL-13. Recent advances have called attention to the contributions by innate cells in initiating adaptive immunity, including a novel lineage-negative population of cells that secretes IL-13 and IL-5 in response to the epithelial cytokines IL-25 and IL-33. Here, we use IL-4 and IL-13 reporter mice to track lineage-negative innate cells that arise during type 2 immunity or in response to IL-25 and IL-33 in vivo. Unexpectedly, lineage-negative IL-25 (and IL-33) responsive cells are widely distributed in tissues of the mouse and are particularly prevalent in mesenteric lymph nodes, spleen, and liver. These cells expand robustly in response to exogenous IL-25 or IL-33 and after infection with the helminth Nippostrongylus brasiliensis, and they are the major innate IL-13-expressing cells under these conditions. Activation of these cells using IL-25 is sufficient for worm clearance, even in the absence of adaptive immunity. Widely dispersed innate type 2 helper cells, which we designate Ih2 cells, play an integral role in type 2 immune responses.


Related Papers

No related papers found

Powered by citation graph analysis